TEMTempus AI, Inc.

Price: $78.25 | Today's Change: +8.35%

---

What Happened

Tempus AI, Inc. filed an 8-K with the SEC on November 2, 2026, disclosing its financial results for Q3 FY2026 under Item 2.02 (Results of Operations and Financial Condition). The company reported revenue of $904,578,000 for the quarter, paired with a net loss of $190,862,000, or $1.10 per share on both a basic and diluted basis. Operating loss for the period came in at $191,459,000, indicating that operating expenses continued to run ahead of gross revenues.

---

Why It Matters

The headline revenue figure of approximately $904.6 million signals that Tempus AI is generating substantial top-line activity, reflecting the scale of its AI-driven healthcare data and analytics platform. However, the operating loss of roughly $191.5 million underscores that the company remains in an investment-heavy phase, with costs materially exceeding operational income. For investors, the key near-term question is whether the rate of revenue growth is sufficient to justify the continuing cash burn — and whether a path toward operating leverage is becoming more visible. The stock's sharp gain of 8.35% on the day suggests the market may be reading the revenue result as a positive data point relative to expectations, even as losses persist.

---

Analysis

The Q3 FY2026 results present the classic growth-versus-profitability tension common to high-investment technology and data platforms. Revenue at the ~$904.6 million level is a meaningful headline, but it is the trajectory — whether growth is accelerating, decelerating, or holding steady — that will shape the market's next read. The operating loss of $191.5 million is essentially in line with the net loss of $190.9 million, suggesting limited below-the-line offsets, which means profitability remains a function of top-line scaling rather than financial engineering.

The strong single-day price move of +8.35% indicates investor sentiment is net positive on this print, even though losses per share remain at $1.10. Watchers of this name should focus on whether management provides updated guidance on the pace of margin improvement and what portion of operating costs are discretionary investments versus structural overhead. Our prior initiating coverage of Tempus AI is worth revisiting in light of these results — a link to that full report will be found in the coverage section of this page.

Key items to monitor going forward:

• Revenue growth rate relative to prior quarters — the absolute dollar figure is only one part of the story
• Pace of operating loss reduction — whether the gap between revenue and operating expenses is narrowing
• Cash position and runway — not provided in this filing's structured data, but critical context for a company still posting ~$191M quarterly operating losses
• Management commentary — any forward guidance embedded in the earnings release (Item 7.01) will be the clearest signal on near-term trajectory

---

Disclaimer

This report is a news and informational summary prepared for general informational purposes only. It is based on data extracted from a publicly filed SEC disclosure and does not constitute investment advice, a solicitation, or an offer to buy or sell any security. No investment rating or price target is expressed or implied in this report. Readers should conduct their own due diligence and consult a qualified financial adviser before making any investment decisions.

Existing Coverage

StockWatch has full coverage on TEM, published 2026-09-15. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-02. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1717115/000119312526442619/tem-20261102.htm